Sponsor or institution

Clinical trials and research at HuidaGene Therapeutics Co., Ltd.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by HuidaGene Therapeutics Co., Ltd. that are recruiting, in China. By phase: Early Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
HG005 two-vector gene therapy for Stargardt disease in children and teens Early Phase 1 Shanghai Recruiting Jul 14, 2025
Evaluating a new CRISPR therapy for MECP2 Duplication Syndrome — Beijing, Beijing Municipality Recruiting Sep 26, 2024
Gene-editing therapy for treating neovascular age-related macular degeneration Early Phase 1 Shanghai, Shanghai Municipality and 1 other locations Recruiting Sep 11, 2023

All recruiting trials (3)

Quick answers

How many clinical trials run by HuidaGene Therapeutics Co., Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.